Characterization of ubiquilin 1, an mTOR-interacting protein
- PMID: 11853878
- DOI: 10.1016/s0167-4889(01)00164-1
Characterization of ubiquilin 1, an mTOR-interacting protein
Abstract
The mTOR protein kinase is known to control cell cycle progression and cell growth through regulation of translation, transcription, membrane traffic and protein degradation. Known interactions of mTOR do not account for the multiple functions of this protein. Using a non-catalytic segment of mTOR (1-670) as bait in a yeast two-hybrid screen for interacting proteins, ubiquilin 1 (NM013438) was identified. Ubiquilin 1 is a member of a phylogenetically conserved gene family of unknown function, characterized by an N-terminal ubiquitin-like (Ubq) domain, a C-terminal ubiquitin associated (Uba) domain and a central region containing numerous NPXvar phi motifs (X, any; phi, hydrophobic amino acid). GST-ubiquilin 1 binds specifically to FLAG-mTOR (residues 1-670) in mammalian cells; residues 570-670 of mTOR and 226-323 of ubiquilin 1 are required for this interaction. Both mTOR and ubiquilin immunoreactivity appear as fine speckles throughout the cytoplasm; significant colocalization with cytoskeletal elements, early endosomes or proteasomes is not observed. As assessed by cell fractionation, mTOR is predominantly associated with low density membranes, along with 10% of ubiquilin 1. Ubiquilin 1 is a rapamycin-insensitive phosphoprotein. Overexpression of ubiquilin 1 does not alter the kinase activity of cotransfected mTOR or the phosphorylation of the mTOR target, p70 S6 kinase, in the presence or absence of rapamycin. Our data suggest that we have identified a novel mTOR interactor, ubiquilin 1. The biological significance of this, presumably membrane based, interaction, requires further study.
Similar articles
-
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.Curr Biol. 2004 Jul 27;14(14):1296-302. doi: 10.1016/j.cub.2004.06.054. Curr Biol. 2004. PMID: 15268862
-
Identification of a conserved motif required for mTOR signaling.Curr Biol. 2002 Apr 16;12(8):632-9. doi: 10.1016/s0960-9822(02)00762-5. Curr Biol. 2002. PMID: 11967149
-
Identification of rictor as a novel substrate of Polo-like kinase 1.Cell Cycle. 2015;14(5):755-60. doi: 10.1080/15384101.2014.998050. Cell Cycle. 2015. PMID: 25714006 Free PMC article.
-
Raptor, a binding partner of target of rapamycin.Biochem Biophys Res Commun. 2004 Jan 9;313(2):437-41. doi: 10.1016/j.bbrc.2003.07.018. Biochem Biophys Res Commun. 2004. PMID: 14684181 Review.
-
TOR action in mammalian cells and in Caenorhabditis elegans.Curr Top Microbiol Immunol. 2004;279:115-38. doi: 10.1007/978-3-642-18930-2_8. Curr Top Microbiol Immunol. 2004. PMID: 14560955 Review.
Cited by
-
Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy.Hum Mol Genet. 2010 Aug 15;19(16):3219-32. doi: 10.1093/hmg/ddq231. Epub 2010 Jun 7. Hum Mol Genet. 2010. PMID: 20529957 Free PMC article.
-
miR-337-5p promotes the development of cardiac hypertrophy by targeting Ubiquilin-1 (UBQLN1).Bioengineered. 2021 Dec;12(1):6771-6781. doi: 10.1080/21655979.2021.1964892. Bioengineered. 2021. PMID: 34515612 Free PMC article.
-
Studies of the role of ubiquitination in the interaction of ubiquilin with the loop and carboxyl terminal regions of presenilin-2.Biochemistry. 2007 Jul 31;46(30):8827-37. doi: 10.1021/bi700604q. Epub 2007 Jul 6. Biochemistry. 2007. PMID: 17614368 Free PMC article.
-
Protein aggregation and degradation mechanisms in neurodegenerative diseases.Am J Neurodegener Dis. 2013;2(1):1-14. Epub 2013 Mar 8. Am J Neurodegener Dis. 2013. PMID: 23516262 Free PMC article.
-
Impaired 26S Proteasome Assembly Precedes Neuronal Loss in Mutant UBQLN2 Rats.Int J Mol Sci. 2021 Apr 21;22(9):4319. doi: 10.3390/ijms22094319. Int J Mol Sci. 2021. PMID: 33919255 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous